Literature DB >> 11118107

Prevention of bone loss with alendronate in kidney transplant recipients.

D Kovac, J Lindic, A Kandus, A F Bren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11118107     DOI： 10.1097/00007890-200011270-00028

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

Review 1.  Bone Disease after Kidney Transplantation.

Authors:  Antoine Bouquegneau; Syrazah Salam; Pierre Delanaye; Richard Eastell; Arif Khwaja
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-15       Impact factor: 8.237

Review 2.  Osteoporosis after renal transplantation.

Authors:  Evangelia Dounousi; Konstantinos Leivaditis; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Int Urol Nephrol       Date:  2014-11-11       Impact factor: 2.370

Review 3.  Management of mineral and bone disorder after kidney transplantation.

Authors:  Kamyar Kalantar-Zadeh; Miklos Z Molnar; Csaba P Kovesdy; Istvan Mucsi; Suphamai Bunnapradist
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

Review 4.  Mineral and bone disorder after renal transplantation: a review.

Authors:  Hazim Sadideen; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2007-12-18       Impact factor: 2.370

Review 5.  Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis.

Authors:  Shun-Li Kan; Guang-Zhi Ning; Ling-Xiao Chen; Yong Zhou; Jing-Cheng Sun; Shi-Qing Feng
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.